The lack of difference in the frequency of DUSP22-R between the leukemic versus non-leukemic ALK-negative ALCL cases suggests that DUSP22 does not play a role in the different outcomes of these two groups of patients. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.